Continuous Theta Burst Stimulation for Generalized Anxiety Disorder
NCT: NCT07770919 · NOT_YET_RECRUITING
Brief Summary
This randomized clinical trial evaluates the effectiveness of continuous theta burst stimulation (cTBS) combined with background pharmacotherapy in patients with generalized anxiety disorder. Participants will be randomly assigned to receive cTBS targeting either the right posterior parietal cortex or the right dorsolateral prefrontal cortex. The study will compare changes in anxiety symptoms between the two treatment strategies and will also assess quality of life, sleep, cognitive function, electroencephalographic measures, and transcranial magnetic stimulation-electroencephalography measures.
Frequently Asked Questions
What is Continuous Theta Burst Stimulation for Generalized Anxiety Disorder?
Continuous Theta Burst Stimulation for Generalized Anxiety Disorder is a clinical trial registered under NCT07770919. Current status: NOT_YET_RECRUITING.
What is the status of NCT07770919?
The current status of NCT07770919 (Continuous Theta Burst Stimulation for Generalized Anxiety Disorder) is: NOT_YET_RECRUITING.
When did Continuous Theta Burst Stimulation for Generalized Anxiety Disorder start?
Continuous Theta Burst Stimulation for Generalized Anxiety Disorder started on 2026-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.